References
- Kemp SV, Polkey MI, Shah PL. The epidemiology, etiology, clinical features, and natural history of emphysema. Thorac Surg Clin. 2009;19(2):149–158.
- Casanova C, Cote C, de Torres JP, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(6):591–597.
- Berton DC, Reis M, Siqueira AC, et al. Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD. Respir Med. 2010;104(9):1288–1296.
- Somfay A, Porszasz J, Lee SM, et al. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. Eur Respir J. 2001;18(1):77–84.
- Santus P, Bassi L, Radovanovic D, et al. Pulmonary rehabilitation in COPD: a reappraisal (2008–2012). Pulm Med. 2013;2013:1–8.
- Cooper JD, Trulock EP, Triantafillou AN, et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg. 1995;109(1):106–109.
- Geddes D, Davies M, Koyama H, et al. Effect of lung-volume-reduction surgery in patients with severe emphysema. N Engl J Med. 2000;343(4):239–245.
- Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348(21):2059–2073.
- Clark SJ, Zoumot Z, Bamsey O, et al. Surgical approaches for lung volume reduction in emphysema. Clin Med. 2014;14(2):122–127.
- Decker MR, Leverson GE, Jaoude WA, et al. Lung volume reduction surgery since the national emphysema treatment trial: study of society of thoracic surgeons database. J Thorac Cardiovasc Surg. 2014;148(6):2651–8.e1.
- Ahmad S, Taneja A, Kurman J, et al. National trends in lung volume reduction surgery in the United States: 2000 to 2010. Chest. 2014;146(6):e228–e229.
- Toma TP, Hopkinson NS, Hillier J, et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet. 2003;361(9361):931–933.
- Sciurba FC, Ernst A, Herth FJ, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010;363(13):1233–1244.
- Herth FJ, Noppen M, Valipour A, et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J. 2012;39(6):1334–1342.
- Davey C, Zoumot Z, Jordan S, et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet. 2015;386(9998):1066–1073.
- Klooster K, Ten Hacken NH, Hartman JE, et al. Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med. 2015;373(24):2325–2335.
- Valipour A, Slebos DJ, Herth F, et al. Endobronchial valve therapy in patients with homogeneous emphysema. Results from the IMPACT study. Am J Respir Crit Care Med. 2016;194(9):1073–1082.
- Kemp SV, Slebos DJ, Kirk A, et al. A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM). Am J Respir Crit Care Med. 2017;196(12):1535–1543.
- Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582.
- Sterman DH, Mehta AC, Wood DE, et al. A multicenter pilot study of a bronchial valve for the treatment of severe emphysema. Respiration. 2010;79(3):222–233.
- Ninane V, Geltner C, Bezzi M, et al. Multicentre European study for the treatment of advanced emphysema with bronchial valves. Eur Respir J. 2012;39(6):1319–1325.
- Eberhardt R, Gompelmann D, Schuhmann M, et al. Complete unilateral vs partial bilateral endoscopic lung volume reduction in patients with bilateral lung emphysema. Chest. 2012;142(4):900–908.
- Spiration, Inc. The spiration valve system for the treatment of severe emphysema (REACH). ClinicalTrials.gov. [cited 2018 Oct 16]. NLM Identifier: NCT01989182. Available from: https://clinicaltrials.gov/ct2/show/NCT01989182
- Spiration, Inc. Evaluation of the spiration® valve system for emphysema to improve lung function (EMPROVE). ClinicalTrials.gov. [cited 2018 Oct 16]. NLM Identifier: NCT01812447. Available from: https://clinicaltrials.gov/ct2/show/NCT01812447
- Trudzinski FC, Lepper PM, Leppert D, et al. Bilateral endoscopic lung volume reduction in patients with severe emphysema. Respiration. 2016;92(5):356–358.
- National Institute for Health Research (UK). CELEB: lung volume reduction in COPD - surgery vs endobronchial valves. isrctn.com. [2018 Oct 16]. NLM Identifier: ISRCTN19684749. Available from: http://www.isrctn.com/ISRCTN19684749
- Hartman JE, Klooster K, Slebos DJ, et al. Improvement of physical activity after endobronchial valve treatment in emphysema patients. Respir Med. 2016;117:116–121.
- Hopkinson NS, Toma TP, Hansell DM, et al. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med. 2005;171(5):453–460.
- Garner J, Kemp SV, Toma TP, et al. Survival after endobronchial valve placement for emphysema: a 10-year follow-up study. Am J Respir Crit Care Med. 2016;194(4):519–521.
- Hopkinson NS, Kemp SV, Toma TP, et al. Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J. 2011;37(6):1346–1351.
- Venuta F, Anile M, Diso D, et al. Long-term follow-up after bronchoscopic lung volume reduction in patients with emphysema. Eur Respir J. 2012;39(5):1084–1089.
- Klooster K, Hartman JE, Ten Hacken NHT, et al. Improved predictors of survival after endobronchial valve treatment in patients with severe emphysema. Am J Respir Crit Care Med. 2017;195(9):1272–1274.
- Eberhardt R, Gompelmann D, Herth FJ, et al. Endoscopic bronchial valve treatment: patient selection and special considerations. Int J Chron Obstruct Pulmon Dis. 2015;10:2147–2157.
- Slebos DJ, Shah PL, Herth FJ, et al. Endobronchial valves for endoscopic lung volume reduction: best practice recommendations from expert panel on endoscopic lung volume reduction. Respiration. 2017;93(2):138–150.
- Herth FJ, Slebos DJ, Rabe KF, et al. Endoscopic lung volume reduction: an expert panel recommendation. Respiration. 2016;91(3):241–250.
- Valipour A, Herth FJ, Burghuber OC, et al. Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy. Eur Respir J. 2014;43(2):387–396.
- Gompelmann D, Eberhardt R, Michaud G, et al. Predicting atelectasis by assessment of collateral ventilation prior to endobronchial lung volume reduction: a feasibility study. Respiration. 2010;80(5):419–425.
- Herth FJ, Eberhardt R, Gompelmann D, et al. Radiological and clinical outcomes of using Chartis to plan endobronchial valve treatment. Eur Respir J. 2013;41(2):302–308.
- Brompton R, Harefield NHS. Foundation trust. LVR in severe emphysema using bronchoscopic autologous blood instillation in combination with intra-bronchial valves (BLOOD-VALVES). ClinicalTrials.gov. [cited 2018 Oct 16]. NLM Identifier: NCT03010449. Available from: https://clinicaltrials.gov/ct2/show/NCT03010449
- PulmonX, Inc; University Medical Center Groningen (UMCG). Proactive treatment of collateral ventilation in CV-positive emphysema patients before EBV treatment. trialregister.nl. [cited 2018 Oct 16]. NLM Identifier: NTR5007. Available from: http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=5007
- de Oliveira HG, de Oliveira SM, Rambo RR, et al. Fissure integrity and volume reduction in emphysema: a retrospective study. Respiration. 2016;91(6):471–479.
- Koster TD, van Rikxoort EM, Huebner RH, et al. Predicting lung volume reduction after endobronchial valve therapy is maximized using a combination of diagnostic tools. Respiration. 2016;92(3):150–157.
- Eberhardt R, Gerovasili V, Kontogianni K, et al. Endoscopic lung volume reduction with endobronchial valves in patients with severe emphysema and established pulmonary hypertension. Respiration. 2015;89(1):41–48.
- Hillerdal G, Mindus S. One- to four-year follow-up of endobronchial lung volume reduction in alpha-1-antitrypsin deficiency patients: a case series. Respiration. 2014;88(4):320–328.
- Eberhardt R, Herth FJ, Radhakrishnan S, et al. Comparing clinical outcomes in upper versus lower lobe endobronchial valve treatment in severe emphysema. Respiration. 2015;90(4):314–320.
- Koenigkam-Santos M, Puderbach M, Gompelmann D, et al. Incomplete fissures in severe emphysematous patients evaluated with MDCT: incidence and interobserver agreement among radiologists and pneumologists. Eur J Radiol. 2012;81(12):4161–4166.
- Schuhmann M, Raffy P, Yin Y, et al. Computed tomography predictors of response to endobronchial valve lung reduction treatment. Comparison with Chartis. Am J Respir Crit Care Med. 2015;191(7):767–774.
- Thomsen C, Theilig D, Herzog D, et al. Lung perfusion and emphysema distribution affect the outcome of endobronchial valve therapy. Int J Chron Obstruct Pulmon Dis. 2016;11:1245–1259.
- Valipour A, Slebos DJ, de Oliveira HG, et al. Expert statement: pneumothorax associated with endoscopic valve therapy for emphysema–potential mechanisms, treatment algorithm, and case examples. Respiration. 2014;87(6):513–521.
- Gompelmann D, Herth FJ, Slebos DJ, et al. Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema. Respiration. 2014;87(6):485–491.
- Gompelmann D, Benjamin N, Kontogianni K, et al. Clinical and radiological outcome following pneumothorax after endoscopic lung volume reduction with valves. Int J Chron Obstruct Pulmon Dis. 2016;11:3093–3099.
- Woodring JH, Baker MD, Stark P. Pneumothorax ex vacuo. Chest. 1996;110(4):1102–1105.
- van Geffen WH, Klooster K, Hartman JE, et al. Pleural adhesion assessment as a predictor for pneumothorax after endobronchial valve treatment. Respiration. 2017;94(2):224–231.
- Gompelmann D, Lim HJ, Eberhardt R, et al. Predictors of pneumothorax following endoscopic valve therapy in patients with severe emphysema. Int J Chron Obstruct Pulmon Dis. 2016;11:1767–1773.
- Klooster K, Hartman JE, Ten Hacken NH, et al. One-year follow-up after endobronchial valve treatment in patients with emphysema without collateral ventilation treated in the STELVIO trial. Respiration. 2017;93(2):112–121.
- Skowasch D, Fertl A, Schwick B, et al. A long-term follow-up investigation of endobronchial valves in emphysema (the LIVE study): study protocol and six-month interim analysis results of a prospective five-year observational study. Respiration. 2016;92(2):118–126.
- Criner GJ, Sue R, Wright S, et al. A multicenter RCT of Zephyr(R) endobronchial valve treatment in heterogeneous emphysema (LIBERATE). Am J Respir Crit Care Med. 2018.
- Sciurba FC, Criner GJ, Strange C, et al. Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: the RENEW randomized clinical trial. JAMA. 2016;315(20):2178–2189.
- Herth FJ, Valipour A, Shah PL, et al. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial. Lancet Respir Med. 2016;4(3):185–193.
- Come CE, Kramer MR, Dransfield MT, et al. A randomised trial of lung sealant versus medical therapy for advanced emphysema. Eur Respir J. 2015;46(3):651–662.
- Shah PL, Slebos DJ, Cardoso PF, et al. Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet. 2011;378(9795):997–1005.
- Heidelberg University. Implantation of endobronchial valves versus intrabronchial valves in patients with severe heterogeneous emphysema. ClinicalTrials.gov. [cited 2018 Oct 16]. NLM Identifier: NCT01457833. Available from: https://clinicaltrials.gov/ct2/show/NCT01457833
- University Medical Center Groningen; Maastricht University Medical Center. A trial on the effects of bronchoscopic lung volume reduction in severe emphysema (SOLVE). ClinicalTrials.gov. [cited 2018 Oct 16]. NLM Identifier: NCT03474471. Available from: https://clinicaltrials.gov/ct2/show/NCT03474471